# The Efficacy of S-adenosyl Methionine (SAMe) Versus Pentoxiphylline in Patients With Non-alcoholic Steatohepatitis With Fibrosis

> **NCT02231333** · NA · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 122 (actual)

## Conditions studied

- Non-alcoholic Steatohepatitis

## Interventions

- **DRUG:** S-adenosylmethionine (SAMe)
- **DRUG:** pentoxiphylline (PTX)

## Key facts

- **NCT ID:** NCT02231333
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07-01
- **Primary completion:** 2015-07-31
- **Final completion:** 2015-07-31
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2019-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02231333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02231333, "The Efficacy of S-adenosyl Methionine (SAMe) Versus Pentoxiphylline in Patients With Non-alcoholic Steatohepatitis With Fibrosis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02231333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*